ADMS Market Cap History
Below is a table of the ADMS market cap history going back to 5/6/2014:

Date ADMS Market Cap

Also see: ADMS Shares Outstanding History
and ADMS YTD Return
ADMS Historical Market Cap:
+1.42% CAGR
ADMS Historical Market Cap: +1.42% CAGR

Mouse over chart for data details
5/6/2014 ...10/31/2021
Adamas Pharmaceuticals focuses on a portfolio of therapies to reduce the burden of neurological diseases on patients, caregivers, and society. Co.'s portfolio includes: GOCOVRI® (amantadine) extended release capsules for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications, and as adjunctive treatment for patients with Parkinson's disease taking levodopa/carbidopa experiencing reemergence or sudden return of stiffness, rigidity and tremors; and OSMOLEX ER® (amantadine) extended release tablets for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adult patients. We show 32 historical shares outstanding datapoints in our ADMS shares outstanding history coverage, used to compute ADMS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADMS market cap history over the course of time is important for investors interested in comparing ADMS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ADMS versus a peer is one thing; comparing ADMS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ADMS can fluctuate over the course of history. With this page we aim to empower investors researching ADMS by allowing them to research the ADMS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ADMS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adamas Pharmaceuticals (ADMS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ADPT Market Cap History
ADRO Market Cap History
ADTX Market Cap History
ADUS Market Cap History
ADVM Market Cap History
ADXS Market Cap History
ADYX Market Cap History
AEMD Market Cap History
AERI Market Cap History
AEZS Market Cap History
More Healthcare companies »


ADMS Market Cap History | | Copyright © 2017 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.